General

The “Investor Series: Opportunities in Women’s Digital Health Market’’ report provides detailed information on the women’s digital health market, covering the core and peripheral women’s digital health solutions   Key Inclusions An executive summary of the insights captured during our research. It offers a high-level view on the current state of women’s digital health market and its likely evolution in the mid-long term along with the financial activity in this domain. An introduction to women’s digital health, highlighting some of the key application areas of the FemTech industry. It features various types of women’s digital health products / solutions that have either been marketed / are under development. In addition, the report highlights prominent barriers to the development and success of women’s digital health solutions, and the opinions of representatives from key stakeholder companies involved in this domain. A detailed analysis of women’s digital health focused companies that were established post-2006, featuring key insights on the observed trends related to the basic company parameters, such as year of establishment, location of headquarters, company size, and type of venture.  An assessment of the various products / solutions, offered by the innovator companies, featuring analysis based on number and types of products. Based on the aforementioned insights, we have developed a quantitative perspective on the relative health (based on the company details, product portfolio, financing activity, estimated revenues and profits) of the different innovator companies that have been described in detail in this report. This analysis is based on a proprietary scoring criterion, informed via secondary research. An informed perspective on the value proposition of the companies captured in the report based on multiple relevant aspects, namely product-related value, value to patients, developer value and outreach-related value. A company competitiveness analysis, which offers a quantitative basis for comparing the strengths / contributions of various industry stakeholders that are involved in providing women’s digital health solutions. It is worth mentioning that this analysis is based on the insights generated from the abovementioned relative health indexing and value proposition analysis. A detailed analysis of the women's digital health funding women's digital health investment activity that has taken place, since 2011. It also includes category-wise financing trends, describing the relative maturity (in terms of number of funding instances and total capital raised) of the innovator companies mentioned in the report. Further, it features a list of the leading investors in women’s digital health, based on their participation in financing activity in this industry segment. An elaborate review of the overall women’s digital health market from a financial perspective, including detailed fundamental (insights from the balance sheet and key financial ratios) and technical analysis (insights from historical and recent stock price variations as well as analysis using popular stock performance indicators) of financial data of the publicly listed companies within the innovators landscape dataset. A key acquisition targets analysis, based on the insights generated during the course of this study, highlighting some of the promising early-to-mid stage business ventures that are likely to be acquired / merged. A case study on the assessment of business risks, based on some of the major risk categories that are usually discussed in the industry, namely operations-related risks, business-related risks, financial / asset-related risks, product / technology risks, and others (social, economic, environmental and political risks). A case study where investors have exited various women’s digital health-related ventures, offering insights on return on investments received (based on availability of data). Leveraging the abovementioned details, the report offers an informed opinion on the future outlook for investors in the women’s digital health market.   The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:   Type of Solution Applications / Software Devices Services   Therapeutic Application Area Fetal Health General Wellness Menstrual Cycle Pelvic Care Reproductive Health / Fertility   Key Geographical Regions North America Europe Asia-Pacific Latin America Middle East and North Africa                                                                                          Key Questions Answered What are the key application areas of the FemTech industry? Who are the innovators offering women’s digital health solutions? What type of women’s digital health products / solutions are being offered by the innovator companies? What are the key value propositions offered by players engaged in the women’s digital health domain? What is the relative competitiveness of different players offering products / solutions focused on women’s health? Who are the key investors that are actively supporting the development and commercialization of women’s digital health products / solutions? What are the anticipated fundamental and technical trends of financial data of publicly listed companies within the innovator landscape? Who are the potential acquisition targets for investors in the women’s digital health sector? What are the major risks for investors seeking to tap into the women’s digital health domain? What is the estimated return on investments received by the investors? How is the current and future market opportunity related to women’s digital health likely to be distributed across key market segments?   Get more details on the report https://www.rootsanalysis.com/reports/opportunities-in-women-digital--health-market.html   You may also be interested in the following titles: Blockchain Technology in Healthcare Market  Autoinjectors   You may also like to learn what our experts are sharing in Roots educational series: Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders 4D Bioprinting Market: Key Trends   About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.   Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com  

The growing concern of patient non-compliance and poor adherence to conventional medication regimen has prompted various biopharmaceutical companies to leverage the expertise of players offering long-acting drug delivery technologies and services   Roots Analysis is pleased to announce the publication of its recent study, titled, “Long-Acting Drug Delivery Market, 2023-2035”   The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes   An executive summary of the insights captured during our research. It offers a high-level view on the current state of long acting drugs delivery technologies and services market and its likely evolution in the mid-long term. A general overview of long-acting drug delivery and the different types of long-acting drug delivery systems. Additionally, it highlights the underlying principles and strategies associated with long-acting drug delivery. A detailed assessment of the current technology landscape of long-acting drug delivery technologies. A detailed assessment of the overall service providers landscape of the companies offering contract services related to long-acting drug delivery. A technology competitiveness analysis of long-acting drug delivery technologies. A company competitiveness analysis of long-acting drug delivery service providers. Elaborate profiles of prominent players developing technologies and offering services in the domain of long-acting drug delivery (shortlisted based on a proprietary criterion). A detailed analysis of the recent partnerships inked between stakeholders engaged in this domain, since 2018. A detailed analysis of over 570 peer-reviewed, scientific articles focused on research related to long-acting drug delivery. An in-depth analysis of various patents that have been filed / granted related to long-acting drug delivery, since 2018. A detailed review of academic grants that have been awarded to various research institutes for projects focused on long-acting drug delivery, since 2018. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) Principle Manipulation of drug release from delivery systems Manipulation of in vivo clearance   Strategy Chemical Modification Micro-encapsulation Long-Acting Hydrogels Long-Acting Implants Long-Acting Microneedles Multivesicular Liposomes Nanocrystal Suspensions Protein Fusion   Compatible Dosage Form Injectables Implantables Oral Dosage Forms Topical / Transdermal Dosage Forms Vaginal Dosage Forms Other Dosage Forms   Type of Molecules Delivered Small Molecules Biologics Other Molecules   Type of Material Used Polymer based Non-polymer based   Key Geographical Regions North America Europe Asia-Pacific Middle East and North Africa   Key companies covered in the report Adare Pharma Solutions AMW Bostal Drug Delivery Creative Biolabs ForDoz Pharma Innocore Pharmaceuticals Integral BioSystems LATITUDE Pharmaceuticals Navin Saxena Research and Technology Centre (NSRT) Samyang Biopharm   To view more details on this report, click on the link https://www.rootsanalysis.com/reports/long-acting-drug-delivery-market.html   You may also be interested in the following titles: Oral Solid Dosage Manufacturing Market Lipid Nanoparticles in Drug Delivery Bioavailability enhancement services market Global Gene Switch Market             About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.   Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com  

Roots Analysis has announced the addition of “Bacteriophage Therapeutics Market, 2022-2035” report to its list of offerings.   Key Market Insights Over 100 bacteriophage therapeutics have either been marketed / are being developed by various well-established and small firms; majority of these therapeutics are being evaluated for the treatment of infectious diseases Around 50% of the pipeline candidates are currently under clinical phase of development; of these, close to 50% are designed for oral and topical administration Multiple clinical studies, evaluating various types of bacteriophage therapeutics among more than 3,000 patients across different centers / hospitals, have been registered worldwide Over the years, the intellectual capital related to bacteriophage therapeutics has grown at a significant pace, with several patents being filed by both industry and non-industry players A notable increase in published scientific literature related to bacterio-phage therapeutics has been observed over the years, demonstrating the growing interest in this domain Various organizations have extended financial support to aid the ongoing research for bacteriophage therapies; currently, the focus, in terms of funds disbursed, is on clinical investigation of bacteriophage therapeutics Several investors, having realized the benefits and future opportunity, have invested over USD 1 billion since 2017 The rising interest of stakeholders is also reflected by the number of partnerships signed in the recent past, involving players located in different geographical regions Our proprietary start-up health indexing analysis confirms the presence of several new entrants that claim to possess the required capabilities for developing bacteriophage therapeutics The bacteriophage market is anticipated to grow at a CAGR of ~10% till 2035; the forecasted opportunity is likely to be distributed across different therapeutic areas, routes of administration, and geographical regions   Table of Content 1.                     PREFACE 1.1.                  Scope of the Report 1.2.                  Market Segmentations 1.3.                  Research Methodology 1.4.                  Key Questions Answered 1.5.                  Chapter Outlines   2.                     EXECUTIVE SUMMARY   3.                     INTRODUCTION 3.1.                  Chapter Overview 3.2.                  Historical Evolution of Bacteriophages 3.3.                  Biology of Bacteriophages 3.4.                  Introduction to Bacteriophage Therapy 3.5.                  Applications of Bacteriophage Therapy 3.6.                  Advantages of Bacteriophage Therapy 3.7.                  Limitations of Bacteriophage Therapy 3.8.                  Conclusion   4.                     BACTERIOPHAGE THERAPEUTICS: MARKET LANDSCAPE 4.1.                  Chapter Overview 4.2.                  Bacteriophage Therapeutics: Drug Pipeline 4.2.1.               Analysis by Phase of Development 4.2.2.               Analysis by Therapeutic Area 4.2.3.               Analysis by Phase of Development and Therapeutic Area 4.2.4.               Analysis by Targeted Bacterial Strain 4.2.5.               Analysis by Target Disease Indication 4.2.6.               Analysis by Type of Therapy 4.2.7.               Analysis by Route of Administration   4.3.                  Information on Bacteriophage Related Technologies   5.                     BACTERIOPHAGE THERAPEUTICS: DEVELOPER LANDSCAPE 5.1.                  Chapter Overview 5.2.                  Bacteriophage Therapeutics: List of Developers 5.2.1.               Analysis by Year of Establishment 5.2.2.               Analysis by Company Size 5.2.3.               Analysis by Location of Headquarters 5.2.4.               Analysis by Company Size and Location of Headquarters 5.2.5.               Leading Developers: Analysis by Number of Bacteriophage Therapeutics   6.                     COMPANY AND DRUG PROFILES 6.1.                  Chapter Overview 6.2.                  Eliava BioPreparations 6.3.                  Micreos 6.4.                  NPO Microgen 6.5.                  ContraFect 6.6.                  Adaptive Phage Therapeutics 6.7.                  Phagelux 6.8.                  Pherecydes Pharma   7.                     CLINICAL TRIAL ANALYSIS 7.1.                  Chapter Overview 7.2.                  Scope and Methodology   7.3.                  Bacteriophage Therapeutics Market: Clinical Trial Analysis   8.                     PATENT ANALYSIS 8.1.                  Chapter Overview 8.2.                  Scope and Methodology   8.3.                  Bacteriophage Therapeutics: Patent Analysis   8.4.                  Bacteriophage Therapeutics: Patent Benchmarking 8.5.                  Bacteriophage Therapeutics: Patent Valuation 8.6.                  List of Leading Patents   9.                     PUBLICATION BENCHMARKING ANALYSIS 9.1.                  Chapter Overview 9.2.                  Scope and Methodology 9.3.                  Publication Benchmarking   10.                   ACADEMIC GRANTS ANALYSIS 10.1.                Chapter Overview 10.2.                Scope and Methodology   10.3.                Bacteriophage Therapeutics: Academic Grant Analysis   11.                   FUNDING AND INVESTMENT ANALYSIS 11.1.                Chapter Overview 11.2.                Types of Funding 11.3.                Bacteriophage Therapeutics Market: List of Funding and Investments 11.4.                Concluding Remarks   12.                   PARTNERSHIPS AND COLLABORATIONS 12.1.                Chapter Overview 12.2.                Partnership Models 12.3.                Bacteriophage Therapeutics: List of Partnerships and Collaborations   13.                   START-UP HEALTH INDEXING 13.1.                Chapter Overview 13.2.                Bacteriophage Therapeutics Developers: Start-ups 13.3.                Benchmarking of Start-ups   14.                   MARKET FORECAST AND OPPORTUNITY ANALYSIS 14.1.                Chapter Overview 14.2.                Scope and Assumptions 14.3.                Forecast Methodology 14.4.                Global Bacteriophage Therapeutics Market, 2022-2035   15.                   CONCLUSION   16.                   EXECUTIVE INSIGHTS 16.1.                Chapter Overview 16.2.                Rime Bioinformatics 16.2.1.             Company Snapshot 16.2.2.             Interview Transcript: Antoine Culot, Chief Executive Officer   16.3.                BiomX 16.4.                Hospices Civils De Lyon 16.5.                Independent Consultant             17.                   APPENDIX I: TABULATED DATA   18.                   APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS   For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html   You may also be interested in the following titles: Nanoparticle Formulation Market mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends Cell Therapy Manufacturing Market Roots Analysis Consulting - the preferred research partner for global firms   About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.   Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com    

Owing to the growing number of clinical trials and complexities associated with patient enrollment, drug developers are increasingly relying on patient recruitment service providers to expediate the drug development timelines   Roots Analysis is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Market (3rd Edition), 2022 – 2035.”   The report features an extensive study of companies engaged in offering patient recruitment services and patient retention services. The study features an in-depth analysis of the key drivers and trends related to this domain. Amongst other elements, the report includes: A general overview of the clinical trials, patient recruitment process, patient recruitment associated services as well as the patient retention strategies employed to prevent drop-out of enrolled individuals from clinical trials. A brief information on the various types of patient outreach methods used by contract service providers in this domain, to identify and enroll patients in clinical trials. A detailed assessment of the overall landscape of patient recruitment companies and patient retention companies offering these services. A detailed competitiveness analysis of patient recruitment and retention service providers, segregated into three peer groups based on company size (small, mid-sized, and large and very large). Elaborate profiles of prominent players offering patient recruitment and retention service, based in North America, Europe and Asia Pacific. An analysis of the partnerships that have been inked by stakeholders engaged in this domain, from 2013-2022. A review of the emerging trends in the patient recruitment industry, including the use of social media, mobile technologies, electronic health records (EHR), real-world evidence (RWE) and artificial intelligence. A detailed discussion on the key growth opportunities in the field of patient recruitment and retention that are likely to impact the evolution of the market over the coming years. A case study on regulatory landscape of patient recruitment, highlighting the regulatory process, guidelines and framework. A brief overview of patient recruitment in clinical trials focused on personalized medicines and rare diseases. A detailed analysis of the annual demand for study participants, taking into account the target patient population in ongoing and planned clinical trials, sponsored by both industry and non-industry players. A detailed assessment on the impact of the COVID-19 pandemic on the patient recruitment and retention services market. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) Patient Recruitment Step Pre-screening Screening   Trial Phase Phase I Phase II Phase III Phase IV   Therapeutic Area Cardiovascular Disorders Oncological Disorders Infectious Diseases CNS Disorders Respiratory Disorders Hematological Disorders Dermatological Disorders Ophthalmic Disorders Others   Key Geographical Regions North America Europe Asia Pacific Latin America Middle East and North Africa Rest of the World    Transcripts of interviews held with the following senior level representatives of stakeholder companies: Susan Fitzpatrick-Napier (Founder and Director, TrialWire) Kate Shaw (Chief Executive Officer and Founder) and Marco Lassandro (Marketing and Communications Manager, Innovative Trials) Simon Klaasen (Co-founder and Managing Director, Link2Trials) Stefan Mayer-Eggersmann (Chief Commercial Officer, Clariness) Ken Shore (Chief Commercial Officer, Continuum Clinical) Hagit Nof (Chief Operation Officer and Business Development Officer, nRollmed) Paul Ivsin (Ex-Managing Director, Seeker Health) Kasturi Lakhe (Inside Sales Specialist, EVERSANA)   Key companies covered in the report BBK Worldwide Continuum Clinical IQVIA United BioSource (UBC) WCG ThreeWire Clariness Fidelis Research Ignite Data Innovative Trials Orphan Reach 3H Medi Solution Buzzreach Current Medical Information Center (CMIC) nRollmed Trialfacts   To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market/245.html   News article Global Cell Free Expression Market Learn from experts:  do you know about these emerging industry trends? mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends 4D Bioprinting Market: Key Trends   About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.   Learn more about Roots Analysis consulting services:  Roots Analysis Consulting - the preferred research partner for global firms   Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com  

The rising demand for greater data reproducibility, accuracy and increased efficiency have prompted the healthcare laboratories to consider shifting from manually-handled processes to using lab automation systems.   Roots Analysis is pleased to announce the publication of its recent study, titled, “Lab Automation Market, 2023-2035”   The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these lab automation systems over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: A detailed assessment of the current market landscape of lab automation system manufacturers engaged in the manufacturing of various lab automation systems.  A detailed competitiveness analysis of lab automation system manufacturers based on several relevant parameters, such as company strength, product diversity and product strength. Elaborate profiles of key players (shortlisted based on a proprietary criterion) engaged in the development of lab automation system across North America, Europe and Asia-Pacific and Rest of the World. Each profile features a brief overview of the company, details related to its financial information (if available), product portfolio, recent developments and an informed future outlook. A detailed analysis of partnerships inked between stakeholders engaged in this domain since 2018, based on several relevant parameters, such as year of partnership, type of partnership, type of partner, type of automation instrument(s), most active players (in terms of number of partnerships) and regional distribution of partnership activity in this domain. An in-depth analysis of various patents that have been filed / granted related to lab automation since 2018, taking into consideration several relevant parameters, such as patent publication year, type of patent, patent jurisdiction, CPC symbols, type of applicant, emerging focus areas and leading players (in terms of number of patents filled / granted) and leading individual assignees. It also features a detailed patent benchmarking analysis and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations). A case study on the lab automation software providers, providing detailed analysis on various parameters such as year of establishment, company size (in terms of number of employees), location of headquarters, type of software, mode(s) of deployment, end-user(s). A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) Stage of Automation Pre-Analytical Stage Analytical Stage Post-Analytical Stage Total Lab Automation Type of Instrument Automated Liquid Handling Systems Automated Microplate Readers Automated Sampling Systems Analyzers Automated Storage and Retrieval Systems (ASRS) Other Instruments End-User Pharmaceutical and Biotechnology Companies Research and Diagnostic Laboratories Other End-Users Key Geographical Region  North America Europe Asia-Pacific Middle East and North Africa Latin America   Key companies covered in the report Abbott Anton Paar BD Beckman Coulter ERWEKA Leuze Ortho Clinical Diagnostics Pall Corporation PerkinElmer Roche Diagnostics Siemens Healthineers SYSTAG   To view more details on this report, click on the link https://www.rootsanalysis.com/reports/lab-automation-market.html   News article Digital Biomanufacturing Market Learn from experts:  do you know about these emerging industry trends? SARM1: A Potential Therapeutic Target For Neurodegenerative Diseases Novel Cell Cytometers: Need of the Hour   Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation   About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.   Learn more about Roots Analysis consulting services:  Roots Analysis Consulting - the preferred research partner for global firms   Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com